Related Experiment Video
Updated: Jan 2, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasis
Åsa Lina M Jönsson1, Elisabeth Bendstrup2, Susie Mogensen3
1Dept of Biomedicine, Aarhus University, Aarhus, Denmark aasajoen@rm.dk.
Background:
Pulmonary alveolar microlithiasis (PAM) is caused by genetic variants in the SLC34A2 gene, which encodes the sodium-dependent phosphate transport protein 2B (NaPi-2b). PAM is characterised by deposition of calcium phosphate concretions (microliths) in the alveoli leading to pulmonary dysfunction. The variant spectrum of SLC34A2 has not been well investigated and it is not yet known whether a genotype-phenotype correlation exists.
Methods:
We collected DNA from 14 patients with PAM and four relatives, and analysed the coding regions of SLC34A2 by direct DNA sequencing. To determine the phenotype characteristics, clinical data were collected and a severity score was created for each variant, based on type and localisation within the protein.
Results:
We identified eight novel allelic variants of SLC34A2 in 14 patients with PAM. Four of these were nonsense variants, three were missense and one was a splice site variant. One patient was heterozygous for two different variants and all other patients were homozygous. Four patients were asymptomatic and 10 patients were symptomatic. The severity of the disease was associated with the variant severity.
Conclusions:
Our findings support a significant role for SLC34A2 in PAM and expand the variant spectrum of the disease. Thus, SLC34A2 variants were detected in all patients and eight novel allelic variants were discovered. An association between disease severity and the severity of the variants was found; however, this needs to be investigated in larger patient populations.
Insights
Genetic variants in the SLC34A2 gene cause Pulmonary Alveolar Microlithiasis (PAM). This study identified eight novel SLC34A2 variants and found a correlation between disease severity and variant severity in PAM patients.
Area of Science:
- Genetics
- Pulmonology
- Molecular Biology
Background:
- Pulmonary Alveolar Microlithiasis (PAM) is a rare genetic disorder.
- It is caused by variants in the SLC34A2 gene, encoding the NaPi-2b phosphate transporter.
- The full spectrum of SLC34A2 variants and their link to disease severity were previously unknown.
Purpose of the Study:
- To investigate the variant spectrum of the SLC34A2 gene in PAM patients.
- To explore the genotype-phenotype correlation in Pulmonary Alveolar Microlithiasis.
- To identify novel genetic variants associated with PAM.
Main Methods:
- DNA sequencing of the SLC34A2 gene in 14 PAM patients and four relatives.
- Analysis of coding regions for genetic variants.
- Clinical data collection and creation of a variant severity score.
Main Results:
- Eight novel allelic variants of SLC34A2 were identified in 14 PAM patients.
- Four nonsense, three missense, and one splice site variant were discovered.
- A correlation between disease severity and the severity of SLC34A2 variants was observed.
Conclusions:
- The study confirms the significant role of SLC34A2 in Pulmonary Alveolar Microlithiasis.
- The identified variants expand the known spectrum of SLC34A2 mutations in PAM.
- A genotype-phenotype correlation suggests variant severity influences disease manifestation, warranting further investigation.
More Related Videos
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Pleiotropy
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...

